Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Launched by NORTHWESTERN UNIVERSITY · Feb 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Fit4Treatment trial is studying how to help older women with gynecologic cancers—like ovarian, cervical, and uterine cancer—become more physically active while they are receiving cancer treatments. The researchers want to find out which of four additional support options, paired with a wearable activity tracker and an app, can best encourage these women to exercise more. The options include a personalized app that addresses specific symptoms, having an exercise partner, getting support from healthcare providers, or receiving coaching.
To be eligible for this study, women need to be over 60 years old and diagnosed with one of the specified cancers. They should also be undergoing or planning to start systemic treatments like chemotherapy. Participants will be encouraged to find someone to exercise with them, which can make the experience more enjoyable. The goal of this study is to improve the quality of life and survival outcomes for these women by increasing their physical activity in a supportive way. If you're interested, it’s important to know that participants need to be able to engage in physical activity safely and should not have serious heart problems or other conditions that could prevent them from participating.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female; \> 60 years of age
- • Diagnosis of endometrial/uterine, ovarian, cervical or vulvar/vaginal cancer
- • Undergoing or planning to undergo any systemic treatment for a gynecologic malignancy (e.g., chemotherapy, immunotherapy, anti-angiogenic therapies, targeted therapies, etc.)
- • Willing to try to identify an exercise partner to participate with them, if needed
- • Fluent in English
- Exclusion Criteria:
- • Uncontrolled cardiovascular disease or other major contraindications to physical activity
- • Active brain metastases
- • Cognitive or functional limitations that preclude a patient's ability to participate in the physical activity intervention
- • Pregnant women or prisoners
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Emma Barber, MD, MS
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials